Rebecca Ihilchik, MA Stacey Johnson, MSc CCRM The discourse around artificial intelligence (AI) is seemingly everywhere nowadays. Increasingly influential in our everyday lives, AI has transformed multiple industries and is only gaining speed. This may lead professionals in the cell and...
Article Provided by Miltenyi Biotec Despite a turbulent market environment, the cell and gene therapy (CGT) field continues to advance, with several groundbreaking therapies slated to receive FDA approval this year alone. The momentum is undeniable. However, the path from clinical development...
Erica Waller Senior Product Manager Cryo Automation and Stores Azenta Life Sciences Burlington, MA, USA Cryopreservation, the process of preserving cells, tissues, and organs at extremely low temperatures, stands out as a pivotal technique in modern medicine. As we push the boundaries of...
by Laine Bodnar Senior Manager Communications CCRM Whether you’ve visited Canada or not, you probably know that it’s famous for beautiful scenery, maple syrup and ice hockey. Canada is also where Drs. James Till and Ernest McCulloch defined the hallmark properties of stem cells in the...
Proprietary Platform Moves Promising Cell Therapy Candidates from Contract to Clinic in Six Months NEWARK, NJ, June 1, 2023 – BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy launched their new LEAP Advanced Therapy...
Meet the Investor Brought to you by the ISCT Business Development & Finance Committee Bryan Poltilove Operating Partner BroadOak Capital Partners As Operating Partner with BroadOak, Mr. Poltilove leads the firm’s investments in Cell and Gene...
Meet the Investor Segment Brought to you by the ISCT Business Development & Finance Committee Jonathan Yeh, PhD Partner & Co-Founder Saisei Ventures Canada Please introduce yourself. What is your background and experience in cell...